.
.
.: "targeted cgrp small molecule antagonists for acute migraine therapy.".
6 unexpected products you should probably avoid if you love animals.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. .